A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann
Actelion (ATLN.S) has confirmed it has been approached by Johnson & Johnson (JNJ.N) about a possible transaction to take over the Swiss drugmaker.
ZURICH Actelion (ATLN.S) has confirmed it has been approached by Johnson & Johnson (JNJ.N) about a possible transaction to take over the Swiss drugmaker.
“There can be no certainty that a transaction will result,” Actelion said in a statement on Friday.
(Reporting by John Revill- editing by Brenna Hughes Neghaiwi)
0 comments
Share
